Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CareRxFRA:29C1 66 Dividend Yield % is 2.42% as of Aug. 09, 2026, which is 130% above its 10-year median of 1.05. GuruFocus rates FRA:29C1 with a GF Score™ of 66/100 and a GF Value™ of €1.37. The stock has 3 warning signs investors should review. Among 275 Healthcare Providers & Services companies, CareRx ranks better than 52.73% on this metric.
As of today (2026-08-09), the Trailing Annual Dividend Yield of CareRx is 2.42%.
Good Sign:
CareRx Corp stock Dividend Yield % is close to 1-year high.
The historical rank and industry rank for CareRx's Dividend Yield % or its related term are showing as below:
FRA:29C1'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.51 Med: 1.05 Max: 2.42
Current: 2.42
During the past 13 years, the highest Dividend Yield of CareRx was 2.42%. The lowest was 0.51%. And the median was 1.05%.
FRA:29C1's Dividend Yield % is ranked better than 52.73% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.23
vs FRA:29C1: 2.42
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for CareRx's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:29C1 vs HCA, THC, DVA: Dividend Yield % Comparison
For the Medical Care Facilities subindustry, CareRx's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CareRx Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CareRx's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where CareRx's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
CareRx Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CAD 0.020000
2026-06-23
2026-06-23
2026-07-09
Cash Dividend
quarterly
CAD:EUR 0.611052
CAD 0.020000
2026-03-19
2026-03-19
2026-04-09
Cash Dividend
quarterly
CAD:EUR 0.619938
CAD 0.020000
2025-12-23
2025-12-23
2026-01-21
Cash Dividend
quarterly
CAD:EUR 0.622812
CAD 0.020000
2025-09-23
2025-09-23
2025-10-15
Cash Dividend
quarterly
CAD:EUR 0.611761
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
CareRx's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.04931126
/
2.04
=
2.42 %
Current Share Price is €2.04. CareRx's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.04931126.
CareRx's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.04888416
/
2.04
=
2.40 %
Current Share Price is €2.04. CareRx's Dividends per Share for the forward twelve months is calculated as €0.01222104 * 4 = €0.04888416.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CareRx (FRA:29C1) has a Dividend Yield % of 2.42% as of Aug. 09, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on CareRx and its competitors. This is 130% above median its historical median of 1.05. Over the past decade, CareRx's Dividend Yield % has ranged from 0.51 to 2.42. According to the industry distribution chart, CareRx ranks #130 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 47.3%.
Is CareRx's Dividend Yield % too high?
CareRx's current Dividend Yield % of 2.42% is 130% above median its 10-year median of 1.05. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 2.42. The Healthcare Providers & Services industry median Dividend Yield % is 2.23. CareRx's value of 2.42% is 8.5% above this industry median. Based on the distribution chart, CareRx ranks #130 out of 275 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CareRx has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does CareRx's Dividend Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CareRx ranks #130 out of 275 companies for Dividend Yield %. This puts CareRx in the upper half of its industry. The industry median Dividend Yield % is 2.23. CareRx's value of 2.42% is 8.5% above this benchmark. Historically, CareRx's own Dividend Yield % has ranged from 0.51 to 2.42 over the past decade. While the company's 10-year median is 1.05 vs. the industry median of 2.23, CareRx has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.23, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CareRx's current Dividend Yield % of 2.42% is 8.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on CareRx and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CareRx's current Dividend Yield % is 2.42%, which is 130% above median its own 10-year median of 1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareRx stock overvalued right now?
CareRx (FRA:29C1) has a current Dividend Yield % of 2.42%. The stock's GF Value™ is €1.37, compared to a current price of €2.04 — trading 48.9% above its estimated fair value. The current Dividend Yield % is 2.42%, which is 130% above median its 10-year median of 1.05 and 8.5% above the Healthcare Providers & Services industry median of 2.23. CareRx's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For CareRx (FRA:29C1), the current Dividend Yield % is 2.42% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CareRx (FRA:29C1) Overvalued in 2026?
Based on GuruFocus' analysis, CareRx stock appears to be overvalued.
The current stock price of €2.04 is trading 48.9% above its estimated GF Value™ of €1.37.
Key valuation signals for FRA:29C1:
Dividend Yield %: 2.42% (130% above median its 10-year median of 1.05)
GF Value™: €1.37 vs. price of €2.04 (48.9% above fair value)
Industry Position: 8.5% above the Healthcare Providers & Services median (#130 of 275)
No single metric tells the full story. See the FRA:29C1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
66GF Score
Get the complete analysis for FRA:29C1
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:29C1 has been successfully added to your 
